Concepedia

Eva María Ciruelos Gil

EM

3

Publications

786

Citations

3

H-Index

2013

Active since

Affiliations

Institute of Cancer Research(Current)

The Christie NHS Foundation Trust

Vall d'Hebron Hospital Universitari

AstraZeneca (United Kingdom)

Royal Marsden Hospital

Eva María Ciruelos Gil is an author at Institute of Cancer Research specializing in cancer therapeutics, oncology, and breast cancer.

Top concepts

Publications per year

2013–2022

3

Publications

3

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

, , +7

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

José Baselga, Patricia Gómez, Richard Greil et al. · Journal of Clinical Oncology · 2013 · 350 citations · Full text

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Richard D. Baird, Mafalda Oliveira, Eva María Ciruelos Gil et al. · Cancer Research · 2021 · 32 citations

, , +13

Rows per page

1–3 of 3